Avalon Globocare Shares Soar 96% After Joining AMD AI Developer Program
Avalon Quantum AI LLC joined AMD’s AI Developer Program, securing cloud credits, development tools, training and access to AMD Instinct accelerators and EPYC processors to advance its automated commentary video engine and enterprise AI platforms. Shares surged 96% Thursday as Avalon gears up for a Q2 2026 KetoAir breathalyzer launch.
1. AMD AI Developer Program Acceptance
Avalon Quantum AI LLC has been accepted into AMD’s AI Developer Program, providing cloud credits, development tools, training and access to AMD Instinct accelerators and EPYC processors.
2. Impact on AI Platforms
Avalon plans to leverage AMD resources to scale its automated commentary video engine and enterprise AI platforms, reinforcing its repositioning as a technology-focused AI leader.
3. KetoAir Breathalyzer Launch Plans
Avalon’s KetoAir handheld breathalyzer, recently renewed for FDA registration, is slated for broader B2B and direct-to-consumer distribution in Q2 2026, aiming to leverage AQAI-driven insights for marketing and sales.
4. Share Price Reaction
Shares jumped 96% to $1.00 on Thursday morning, reflecting investor enthusiasm over the AMD partnership and upcoming product milestones.